5 Key Facts About Shingrix Recombinant Zoster Vaccine VIS

As we get older, the chance of getting shingles goes up a lot. Shingles is a serious disease caused by the varicella-zoster virus. The Shingrix vaccine, a recombinant zoster vaccine, is highly recommended to stop shingles and its bad effects. The CDC says Shingrix is best for adults 50 and older.

Studies show Shingrix works really well against shingles. It’s 97% effective for people 50-59 years old. For those 70 and older, it’s 91% effective. We’ll look into the Shingrix vaccine’s details, like how it’s given, side effects, and how it helps against postherpetic neuralgia.

Key Takeaways

• The Shingrix vaccine is given in two doses.
• It offers strong protection against shingles, with 97% efficacy in adults 50-59 years.
• The vaccine is recommended for adults aged 50 years and older.
• Common side effects and protective benefits against postherpetic neuralgia will be discussed.
• Understanding the Shingrix VIS is key for making smart vaccination choices.

What You Need to Know About Shingles Disease

Shingles, also known as herpes zoster, is a viral infection that causes a painful rash. It happens when the varicella-zoster virus, the same virus that causes chickenpox, reactivates. The CDC says about 1 in 3 people in the United States will get shingles at some point in their lives.

Varicella-Zoster Virus Reactivation

The varicella-zoster virus stays hidden in nerve cells after someone gets over chickenpox. Later, it can wake up and travel down nerve fibers, causing shingles. We don’t know why it wakes up, but it happens more often in older adults and those with weak immune systems.

This reactivation of the virus leads to shingles, a painful rash on one side of the body. It can also bring other symptoms like fever, headache, and tiredness.

Serious Complications Including PHN

Shingles can cause serious problems, like postherpetic neuralgia (PHN). This is a condition with long-lasting nerve pain that can last months or years after the rash goes away. Other serious issues can include pneumonia, vision problems, and skin infections.

Some serious complications of shingles include:

• Postherpetic neuralgia (PHN)
• Pneumonia
• Vision problems, including blindness
• Bacterial infections of the skin

For more detailed information on the Shingrix recombinant zoster vaccine, you can refer to the Vaccine Information Statement.

Zoster Recombinant Vaccine Efficacy and Protection

Clinical trials have shown that the recombinant zoster vaccine provides robust protection against shingles. The vaccine’s efficacy has been a key reason for its recommendation for adults aged 50 and older.

97.2% Efficacy in Adults 50+

The Shingrix vaccine has shown 97.2% efficacy in preventing shingles in adults aged 50 and older. This high rate shows the vaccine’s strong protection in this age group. It helps prevent shingles and its complications.

91.3% Efficacy in Adults 70+

In adults aged 70 and older, the vaccine has shown 91.3% efficacy in preventing shingles. This is key because the risk of shingles and its complications grows with age. The CDC notes the vaccine’s effectiveness in older adults as a major reason for its recommendation.

For more information, visit the CDC’s Advisory Committee on Immunization Practices (ACIP) grade for Herpes.

85.5% Protection Against Postherpetic Neuralgia

Postherpetic neuralgia (PHN) is a serious complication of shingles, causing long-lasting pain. The Shingrix vaccine offers 85.5% protection against PHN. This greatly reduces the risk of this painful condition.

Understanding the Shingrix vaccine’s efficacy helps people make informed health choices. Its high efficacy in different age groups makes it a key tool in preventing shingles and PHN.

Shingrix Administration and Dosing Schedule

Knowing how to get the most out of Shingrix is key to fighting shingles. The vaccine is given in two doses.

Two-Dose Series Requirements

Shingrix is a two-dose series vaccine. This is important for the best protection against shingles. So, you need to get two doses of the vaccine.

Timing Between First and Second Doses

The CDC says the second dose of Shingrix should come 2 to 6 months after the first. But, for those with weak immune systems, it can be 1 to 2 months sooner. This makes sure everyone can get the vaccine’s benefits.

“The two-dose series of Shingrix provides robust protection against shingles and postherpetic neuralgia,” as stated by the CDC.

Common Side Effects and Safety Information

It’s important to know about the side effects of the Shingrix vaccine. This knowledge helps make the vaccination process smoother. The Centers for Disease Control and Prevention (CDC) keeps a close eye on vaccine safety.

Expected Reactions After Vaccination

After getting the Shingrix vaccine, you might feel some side effects. The CDC says the most common ones are pain, redness, and swelling where you got the shot. You might also feel tired, have muscle pain, or a headache. These feelings are usually mild and go away in a few days.

Some people might feel arm soreness, fatigue, or mild fever. Feeling tired or having muscle pain is common after the vaccine. These symptoms are usually short-lived and can be helped with over-the-counter pain relievers.

When to Seek Medical Attention

Even though serious side effects from the Shingrix vaccine are rare, it’s important to know when to get help. If you have a severe allergic reaction, trouble breathing, or swelling in your face, lips, tongue, or throat, call your doctor right away.

If you have a fever that lasts more than a few days or if your side effects get worse, talk to your doctor. It’s always safer to be cautious with your health.

By knowing about possible side effects and when to get medical help, you can make smart choices about your health and vaccination experience.

Conclusion: Understanding Your Vaccine Information Statement

We’ve looked into the Shingrix recombinant zoster vaccine. This includes how well it works, how it’s given, and possible side effects. Knowing about the vaccine information statement (VIS) from the CDC is key to making smart vaccine choices.

The Shingrix VIS talks about the vaccine’s good points and possible downsides. It also gives tips on how to get the vaccine. Reading this document helps people understand what to expect when they get vaccinated.

The CDC’s VIS for Shingrix is a must-read for anyone thinking about getting vaccinated against shingles. We suggest taking the time to read it well. Then, talk to your doctor about any questions or worries you have.

Being informed about the Shingrix vaccine and its VIS helps us make good health choices. It’s a step towards preventing shingles and its serious problems.

FAQ

This article reviews the brief history, efficacy, and safety of the two vaccines and discusses the advantage of RZV over LZV based on the available literature
https://pmc.ncbi.nlm.nih.gov/articles/PMC7336348/